Benjamin Kornitzer - 14 Sep 2021 Form 4 Insider Report for agilon health, inc. (AGL)

Role: Chief Med. & Quality Officer
Signature: /s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Issuer symbol: AGL
Transactions as of: 14 Sep 2021
Net transactions value: -$280,908
Form type: 4
Filing time: 15 Sep 2021, 17:19:50 UTC
Next filing: 29 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGL	Common Stock	Options Exercise	$51,638	+11,475	+211%	$4.50^*	16,909	14 Sep 2021	Direct	F1
transaction	AGL	Common Stock	Sale	$332,546	-11,475	-68%	$28.98	5,434	14 Sep 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGL	Options (Rights to Buy)	Options Exercise	$0	-11,475	-2.1%	$0.000000	538,525	14 Sep 2021	Common Stock	11,475	$4.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes restricted stock units.
F2	These options were granted on January 31, 2020. 25% of the options vested on January 9, 2021 and the remaining options are scheduled to vest in three equal installments on each anniversary of January 9, 2021, subject to continued employment.